Multifocal IOL

Multifocal IOL

 

Multifocal IOL

   
LASIK
Multifocal IOL
Implantable Collamer
Lens (ICL)
Phakic Intraocular Lens Implants (IOLs) are essentially contact lenses placed inside the eye on top of the natural crystalline lens, or attached to the iris (colored part of the eye). Because no cornea tissue is removed (as is done with LASIK), a Phakic IOL can correct extreme levels of nearsightedness and farsightedness. Another benefit is that it can be removed, and its effects potentially reversed.

Dougherty Laser Vision offers two types of Phakic IOLs: The Staar Implantable Contact Lens (ICL) and the Verisys (Artisan) Lens. Dr. Dougherty is currently participating in an FDA clinical study of the Staar ICL as a treatment for farsightedness. The Verisys lens was approved by the FDA in 2004 for treating nearsightedness.

Refractive Lensectomy involves removing the natural lens of the eye with ultrasonic energy and replacing it with an intraocular lens (IOL) implant to treat high levels of nearsightedness, farsightedness and astigmatism. This surgery is typically reserved for patients over age 50 whose lens has stiffened and lost the ability to focus. These patients are also likely to begin to develop early cataracts that can cloud vision. Refractive lensectomy is essentially cataract surgery with an intraocular lens implant to decrease dependence on glasses and contacts. LASIK is often used after lensectomy to fine tune the results obtained with the IOL. Patients who have lensectomy will never need cataract surgery. The lens that is placed in the eye is typically well tolerated and will outlive the patient.

Several different types of IOLs may be used in this procedure:

        Traditional IOLs treat a wide range of vision problems from high nearsightedness to high farsightedness. These lenses do not correct astigmatism or accommodate to restore partial reading vision.

        Toric IOLs treat a wide range of vision problems from high nearsightedness to high farsightedness, but also have the benefit of treating astigmatism at the same time.

Accomodating and Multifocal IOLs are designed to provide clear near, intermediate and far vision to help people with presbyopia (i.e., age-related loss of zooming power) become less dependent on bifocal eyeglasses. Approved by the FDA in 2003, the Crystalens is an accomodating IOL equipped with tiny hinges that allow it to move back and forth, or "accommodate," in a design intended to provide seamless clear vision. Approved in 2005, the ReZoom lens is a multifocal lens with five distinct focusing zones intended to provide clear vision at wide range of distance.